Our Mission

CAYR is on a mission to develop drugs for patients with grievous ultra-orphan diseases. By using systematic assessment of the treatment landscape and informed diligence on the latest developments, we unlock the potential for existing therapeutics in novel disease indications. CAYR's efficient, de-centralized incubation structure enables focus in distinct disease areas across subsidiaries